These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33247501)

  • 1. Not only gustatory sweating and flushing: Signs and symptoms associated to the Frey syndrome and the role of botulinum toxin A therapy.
    Marchese MR; Bussu F; Settimi S; Scarano E; Almadori G; Galli J
    Head Neck; 2021 Mar; 43(3):949-955. PubMed ID: 33247501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of medical thermography in treatment of Frey's syndrome with botulinum toxin A.
    Green RJ; Endersby S; Allen J; Adams J
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):90-2. PubMed ID: 24238875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Frey syndrome.
    de Bree R; van der Waal I; Leemans CR
    Head Neck; 2007 Aug; 29(8):773-8. PubMed ID: 17230557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A.
    Tugnoli V; Marchese Ragona R; Eleopra R; Quatrale R; Capone JG; Pastore A; Montecucco C; De Grandis D
    Clin Auton Res; 2002 Jun; 12(3):174-8. PubMed ID: 12269549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of botulinum toxin A in the treatment of gustatory sweating].
    Küttner C; Tröger M; Dempf R; Eckardt A
    Nervenarzt; 2001 Oct; 72(10):787-90. PubMed ID: 11688180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frey syndrome: treatment with type A botulinum toxin.
    von Lindern JJ; Niederhagen B; Bergé S; Hägler G; Reich RH
    Cancer; 2000 Oct; 89(8):1659-63. PubMed ID: 11042557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome.
    Laccourreye O; Akl E; Gutierrez-Fonseca R; Garcia D; Brasnu D; Bonan B
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):283-6. PubMed ID: 10190799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Frey syndrome using botulinum neurotoxin: a case report.
    Ng S; Torjek C; Hovan A
    J Can Dent Assoc; 2009 Nov; 75(9):651-4. PubMed ID: 19900355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A].
    Laccourreye O; Muscatello L; Gutierrez-Fonseca R; Seckin S; Brasnu D; Bonan B
    Ann Otolaryngol Chir Cervicofac; 1999 Jun; 116(3):137-42. PubMed ID: 10399528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes.
    Kyrmizakis DE; Pangalos A; Papadakis CE; Logothetis J; Maroudias NJ; Helidonis ES
    J Oral Maxillofac Surg; 2004 Jul; 62(7):840-4. PubMed ID: 15218563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Treatment for Cancer-Related Disorders: A Systematic Review.
    Safarpour D; Jabbari B
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frey syndrome: diagnosis and treatment].
    Budziński R
    Otolaryngol Pol; 1999; 53(6):687-91. PubMed ID: 10763320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auriculotemporal Syndrome (Frey Syndrome).
    Motz KM; Kim YJ
    Otolaryngol Clin North Am; 2016 Apr; 49(2):501-9. PubMed ID: 26902982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study.
    Laccourreye O; Muscatelo L; Naude C; Bonan B; Brasnu D
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):52-5. PubMed ID: 9439389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Prevalence of Typical and Atypical Symptoms of Frey's Syndrome after Parotidectomy for Benign Tumor.
    Marchese MR; Rossi F; Settimi S; Galli J
    J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin for treatment of gustatory sweating. A prospective randomized study].
    Nolte D; Gollmitzer I; Loeffelbein DJ; Hölzle F; Wolff KD
    Mund Kiefer Gesichtschir; 2004 Nov; 8(6):369-75. PubMed ID: 15517441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Minor's test in Frey syndrome treated with botulinum toxin: Methodology and efficacy.
    Marchese MR; Vollono C; Rigon L; Almadori G; Bentivoglio AR; Petracca M
    Am J Otolaryngol; 2023; 44(3):103818. PubMed ID: 36878174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome).
    Hartl DM; Julieron M; LeRidant AM; Janot F; Marandas P; Travagli JP
    J Laryngol Otol; 2008 Oct; 122(10):1100-4. PubMed ID: 18289458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
    Glaser DA
    Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.